Increased deposition of chondroitin/dermatan sulfate glycosaminoglycan and upregulation of β1,3-glucuronosyltransferase I in pulmonary fibrosis

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 300, Issue 2, 2011, Pages

  Venkatesan, Narayanan ^a   Ouzzine, Mohamed ^b   Kolb, Martin ^c   Netter, Patrick ^b   Ludwig, Mara S ^a  

^a MCGILL UNIVERSITY   (Canada)

^b Biopôle de l Université de Lorraine   (France)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Bleomycin; Fibroblasts; Proteoglycans

Indexed keywords

BETA1,3 GLUCURONOSYL TRANSFERASE 1; BLEOMYCIN; CHONDROITIN; DERMATAN SULFATE; GLUCURONOSYLTRANSFERASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VERSICAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LUNG BIOPSY; LUNG FIBROBLAST; LUNG FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RAT; UPREGULATION;

ANIMALS; BLEOMYCIN; CELLS, CULTURED; CHONDROITIN SULFATES; DERMATAN SULFATE; DISEASE MODELS, ANIMAL; FIBROBLASTS; GLUCURONOSYLTRANSFERASE; HUMANS; HYALURONIC ACID; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MALE; PULMONARY FIBROSIS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TISSUE DISTRIBUTION; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 79551540258     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00214.2010     Document Type: Article

References (47)

1. Al Jamal R, Roughley PJ, Ludwig MS. Effect of glycosaminoglycan degradation on lung tissue viscoelasticity. Am J Physiol Lung Cell Mol Physiol 280: L306-L315, 2001.
2. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 165: 277-304, 2002.
3. Bai X, Wei G, Sinha A, Esko JD. Chinese hamster ovary cell mutants defective in glycosaminoglycan assembly and glucuronosyltransferase I. J Biol Chem 274: 13017-13024, 1999.
4. Bensadoun ES, Burke AK, Hogg JC, Roberts CR. Proteoglycan deposition in pulmonary fibrosis. Am J Respir Crit Care Med 154: 1819-1828, 1996.
5. Calabro A, Hascall VC, Midura RJ. Adaptation of FACE methodology for microanalysis of total hyaluronan and chondroitin sulfate composition from cartilage. Glycobiology 10: 283-293, 2000.
6. Calabro A, Midura R, Wang A, West L, Plaas A, Hascall VC. Fluorophore-assisted carbohydrate electrophoresis (FACE) of glycosaminoglycans. Osteoarthritis Cartilage 9, Suppl A: S16-S22, 2001.
7. Cavalcante FS, Ito S, Brewer KK, Sakai H, Alencar AM, Almeida MP, Andrade JS Jr, Majumdar A, Ingenito EP, Suki B. Mechanical interactions between collagen and proteoglycans: implications for the stability of lung tissue. J Appl Physiol 98: 672-679, 2005.
8. Dadlani H, Ballinger ML, Osman N, Getachew R, Little PJ. Smad and p38 MAP kinase-mediated signaling of proteoglycan synthesis in vascular smooth muscle. J Biol Chem 283: 7844-7852, 2008.
9. D'Antoni ML, Torregiani C, Ferraro P, Michoud MC, Mazer B, Martin JG, Ludwig MS. Effects of decorin and biglycan on human airway smooth muscle cell proliferation and apoptosis. Am J Physiol Lung Cell Mol Physiol 294: L764-L771, 2008.
10. Darby IA, Hewitson TD. Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol 257: 143-179, 2007.
11. Ebihara T, Venkatesan N, Tanaka R, Ludwig MS. Changes in extracellular matrix and tissue viscoelasticity in bleomycin-induced lung fibrosis. Am J Respir Crit Care Med 162: 1569-1576, 2000.
12. English JM, Cobb MH. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci 23: 40-45, 2002.
13. Faggian J, Fosang AJ, Zieba M, Wallace MJ, Hooper SB. Changes in versican and chondroitin sulfate proteoglycans during structural development of the lung. Am J Physiol Regul Integr Comp Physiol 293: R784-R792, 2007.
14. Farndale RW, Sayers CA, Barrett AJ. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 9: 247-248, 1982.
15. Frevert CW, Sannes PL. Matrix proteoglycans as effector molecules for epithelial cell function. Eur Respir Rev 14: 137-144, 2005.
16. Gouze JN, Bordji K, Gulberti S, Terlain B, Netter P, Magdalou J, Fournel-Gigleux S, Ouzzine M. Interleukin-1β down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: influence of glucosamine on interleukin-1β-mediated effects in rat chondrocytes. Arthritis Rheum 44: 351-360, 2001.
17. Handel TM, Johnson Z, Crown SE, Lau EK, Proudfoot AE. Regulation of protein function by glycosaminoglycans-as exemplified by chemokines. Annu Rev Biochem 74: 385-410, 2005.
18. Hiyama A, Gogate SS, Gajghate S, Mochida J, Shapiro IM, Risbud MV. BMP-2 and TGF-β stimulate expression of β1,3-glucuronosyl transferase 1 (GlcAT-1) in nucleus pulposus cells through AP1, TonEBP, and Sp1: role of MAPKs. J Bone Miner Res 25: 1179-1190, 2010.
19. Hwang HY, Olson SK, Esko JD, Horvitz HR. Caenorhabditis elegans early embryogenesis and vulval morphogenesis require chondroitin biosynthesis. Nature 423: 439-443, 2003.
20. Inman GJ, Nicolás FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS. SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62: 65-74, 2002.
21. Iozzo RV. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 67: 609-652, 1998.
22. Kai Y, Yoneyama H, Koyama J, Hamada K, Kimura H, Matsushima K. Treatment with chondroitinase ABC alleviates bleomycin-induced pulmonary fibrosis. Med Mol Morphol 40: 128-140, 2007.
23. Kang JS, Liu C, Derynck R. New regulatory mechanisms of TGF-β receptor function. Trends Cell Biol 19: 385-394, 2009.
24. Kelly MM, Leigh R, Gilpin SE, Cheng E, Martin GE, Radford K, Cox G, Gauldie J. Cell-specific gene expression in patients with usual interstitial pneumonia. Am J Respir Crit Care Med 174: 557-565, 2006.
25. Kisseleva T, Brenner DA. Mechanisms of fibrogenesis. Exp Biol Med (Maywood) 233: 109-122, 2008.
26. Laping NJ, Grygielko E, Mathur A, Butter S, Bomberger J, Tweed C, Martin W, Fornwald J, Lehr R, Harling J, Gaster L, Callahan JF, Olson BA. Inhibition of transforming growth factor (TGF)-β1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharmacol 62: 58-64, 2002.
27. Massagué J. How cells read TGF-β signals. Nat Rev Mol Cell Biol 1: 169-178, 2000.
28. Mizuguchi S, Uyama T, Kitagawa H, Nomura KH, Dejima K, Gengyo-Ando K, Mitani S, Sugahara K, Nomura K. Chondroitin proteoglycans are involved in cell division of Caenorhabditis elegans. Nature 423: 443-448, 2003.
29. Monzon ME, Casalino-Matsuda SM, Forteza RM. Identification of glycosaminoglycans in human airway secretions. Am J Respir Cell Mol Biol 34: 135-141, 2006.
30. Moore BB, Hogaboam CM. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 294: L152-L160, 2008.
31. Moustakas A, Heldin CH. The regulation of TGF-β signal transduction. Development 136: 3699-3714, 2009.
32. Nandini CD, Sugahara K. Role of the sulfation pattern of chondroitin sulfate in its biological activities and in the binding of growth factors. Adv Pharmacol 53: 253-279, 2006.
33. Prante C, Milting H, Kassner A, Farr M, Ambrosius M, Schön S, Seidler DG, Banayosy AE, Körfer R, Kuhn J, Kleesiek K, Götting C. Transforming growth factor β1-regulated xylosyltransferase I activity in human cardiac fibroblasts and its impact for myocardial remodeling. J Biol Chem 282: 26441-26449, 2007.
34. Raman R, Sasisekharan V, Sasisekharan R. Structural insights into biological roles of protein-glycosaminoglycan interactions. Chem Biol 12: 267-277, 2005.
35. Roberts CR, Wight TN, Hascall VC. Proteoglycans. In: The Lung: Scientific Foundations (2nd ed.), edited by Crystal R, West J, Weibel E, and Barnes P. Philadelphia, PA: Lippincott-Raven Press, 1997, p. 757-767.
36. Souza-Fernandes AB, Pelosi P, Rocco PR. Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease. Crit Care 10: 237-252, 2006.
37. Sugahara K, Kitagawa H. Recent advances in the study of the biosynthesis and functions of sulphated glycosaminoglycans. Curr Opin Struct Biol 10: 518-527, 2000.
38. Sugahara K, Mikami T, Uyama T, Mizuguchi S, Nomura K, Kitagawa H. Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Curr Opin Struct Biol 13: 612-620, 2003.
39. Suzuki K, Yamamoto T, Usui T, Suzuki K, Heldin P, Yamashita H. Expression of hyaluronan synthase in intraocular proliferative diseases: regulation of expression in human vascular endothelial cells by transforming growth factor-beta. Jpn J Ophthalmol 47: 557-564, 2003.
40. Tanimoto K, Suzuki A, Ohno S, Honda K, Tanaka N, Doi T, Yoneno K, Ohno-Nakahara M, Nakatani Y, Ueki M, Tanne K. Effects of TGF-β on hyaluronan anabolism in fibroblasts derived from the synovial membrane of the rabbit temporomandibular joint. J Dent Res 83: 40-44, 2004.
41. Taylor KR, Gallo RL. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J 20: 9-22, 2006.
42. Venkatesan N, Barré L, Benani A, Netter P, Magdalou J, Fournel-Gigleux S, Ouzzine M. Stimulation of proteoglycan synthesis by glucuronosyltransferase-I gene delivery: a strategy to promote cartilage repair. Proc Natl Acad Sci USA 101: 18087-18092, 2004.
43. Venkatesan N, Ebihara T, Roughley PJ, Ludwig MS. Alterations in large and small proteoglycans in bleomycin-induced pulmonary fibrosis in rats. Am J Respir Crit Care Med 161: 2066-2073, 2000.
44. Venkatesan N, Roughley PJ, Ludwig MS. Proteoglycan expression in bleomycin lung fibroblasts: role of transforming growth factor-β1 and interferon-γ. Am J Physiol Lung Cell Mol Physiol 283: L806-L814, 2002.
45. Westergren-Thorsson G, Hernnas J, Sarnstrand B, Oldberg A, Heinegard D, Malmstrom A. Altered expression of small proteoglycans, collagen, and transforming growth factor-β1 in developing bleomycin-induced pulmonary fibrosis in rats. J Clin Invest 92: 632-637, 1993.
46. Wilson MS, Wynn TA. Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol 2: 103-121, 2009.
47. Zou XH, Jiang YZ, Zhang GR, Jin HM, Nguyen TM, Ouyang HW. Specific interactions between human fibroblasts and particular chondroitin sulfate molecules for wound healing. Acta Biomater 5: 1588-1595, 2009.